Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.

Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM.

Am J Psychiatry. 2004 Sep;161(9):1642-9.

PMID:
15337655
2.

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee YJ, Nandy S, Pecknold JC, Hadrava V, Swinson RP.

Am J Psychiatry. 2001 Feb;158(2):275-81.

PMID:
11156811
3.

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM.

J Clin Psychiatry. 2003 Jul;64(7):785-92.

PMID:
12934979
4.

Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.

Brawman-Mintzer O, Knapp RG, Rynn M, Carter RE, Rickels K.

J Clin Psychiatry. 2006 Jun;67(6):874-81.

PMID:
16848646
6.
8.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
9.

A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD.

J Clin Psychiatry. 2002 Jan;63(1):66-74.

PMID:
11838629
10.

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.

Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Sertraline Elderly Depression Study Group..

Am J Psychiatry. 2003 Jul;160(7):1277-85.

PMID:
12832242
11.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
12.

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.

Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.

JAMA. 2000 Apr 12;283(14):1837-44.

PMID:
10770145
13.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
14.

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

Ravindran AV, Guelfi JD, Lane RM, Cassano GB.

J Clin Psychiatry. 2000 Nov;61(11):821-7.

PMID:
11105734
15.

Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

Mehtonen OP, S√łgaard J, Roponen P, Behnke K.

J Clin Psychiatry. 2000 Feb;61(2):95-100.

PMID:
10732656
16.

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.

Rynn MA, Siqueland L, Rickels K.

Am J Psychiatry. 2001 Dec;158(12):2008-14.

PMID:
11729017
17.

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

Rickels K, Zaninelli R, McCafferty J, Bellew K, Iyengar M, Sheehan D.

Am J Psychiatry. 2003 Apr;160(4):749-56.

PMID:
12668365
18.

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.

Davidson JR, Bose A, Korotzer A, Zheng H.

Depress Anxiety. 2004;19(4):234-40.

PMID:
15274172
19.

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.

Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM.

Arch Gen Psychiatry. 2001 May;58(5):485-92.

PMID:
11343529
20.

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.

Depress Anxiety. 2008;25(3):182-9.

PMID:
17311303

Supplemental Content

Support Center